Brenk lab

Professor Ruth Brenk

The overall research goal of the Brenk lab is to improve methods used for structure-based drug design and to apply these methods to design inhibitors for enzymes with biological relevance. A key point in our research is the interplay of theoretical and experimental methods.

For more details, check out our research page.

TargetRNA

Funding for interdisciplinary MSCA doctoral training network about targeting RNA with small molecules

TargetRNA is an EU Horizon funded Marie Skłodowska-Curie Action (MSCA) doctoral training network. In this network, 16 PhD students will be trained in RNA-ligand design in the context of antimicrobial drug discovery.

Themed collecction

Interested in RNA-ligand design?

Check out a themed collection about RNA-ligand design in RSC Med. Chem.

New article published

On the Hunt for Metalloenzyme Inhibitors

The Brenk lab has published an article in which they have investigated the presence of metal-coordinating groups in screening libraries and chemical spaces. This can help with the discovery for new inhibitors for metallo enzymes.

Use cases for the EU-OS fragment screening library

Design, Quality and Validation of the EU-OPENSCREEN Fragment Library Poised to a High-Throughput Screening Collection

The Brenk lab has co-authored a paper describing the EU-Openscreen fragment library.

Drug discovery meeting

Ludvik Espeland presenting at the drug disocvery meeting.

Drug Discovery get together

In March, we had a Drug Discovery meeting to showcase the research that is going on Bergen and to connect the groups active in this area. Nearly 50 people had signed up of the meeting and we had 9 different talks covering topics from target discovery all the way to clinical trials.

We offer topics for the degree MSc in the area of structure-based drug design, e.g. molecular modelling, fragment screening and X-ray crystallography. Don't hestitate to contact us for chat to discuss what exactly we can offer and how we can tailor this to match your interests.

The Brenk Lab is part of the Research Unit Structural biology and drug discovery.